23.03
price down icon2.50%   -0.59
after-market Handel nachbörslich: 22.02 -1.01 -4.39%
loading
Schlusskurs vom Vortag:
$23.62
Offen:
$23.49
24-Stunden-Volumen:
123.05K
Relative Volume:
0.86
Marktkapitalisierung:
$842.36M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-9.22%
1M Leistung:
+10.72%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
Value
$22.27
$23.59
1-Wochen-Bereich:
Value
$22.27
$27.48
52-Wochen-Spanne:
Value
$16.55
$29.74

Rapport Therapeutics Inc Stock (RAPP) Company Profile

Name
Firmenname
Rapport Therapeutics Inc
Name
Telefon
857-321-8020
Name
Adresse
1325 BOYLSTON STREET, BOSTON
Name
Mitarbeiter
0
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
RAPP's Discussions on Twitter

Rapport Therapeutics Inc Aktie (RAPP) Neueste Nachrichten

pulisher
Nov 04, 2024

Rapport Therapeutics to Present at Stifel Healthcare - GlobeNewswire

Nov 04, 2024
pulisher
Nov 04, 2024

Rapport Therapeutics to Present at Stifel Healthcare Conference and Jefferies London Healthcare Conference in November - StockTitan

Nov 04, 2024
pulisher
Nov 03, 2024

Rapport Therapeutics (NASDAQ:RAPP) Shares Gap Up – Still a Buy? - Defense World

Nov 03, 2024
pulisher
Nov 01, 2024

Rapport Therapeutics (NASDAQ:RAPP) Shares Gap UpHere's Why - MarketBeat

Nov 01, 2024
pulisher
Oct 28, 2024

SG Americas Securities LLC Makes New Investment in Rapport Therapeutics (NASDAQ:RAPP) - Defense World

Oct 28, 2024
pulisher
Oct 28, 2024

(RAPP) Trading Report - Stock Traders Daily

Oct 28, 2024
pulisher
Oct 25, 2024

Rapport Therapeutics (NASDAQ:RAPP) Trading Down 4.2%Here's Why - MarketBeat

Oct 25, 2024
pulisher
Oct 21, 2024

Rapport Therapeutics (NASDAQ:RAPP) Shares Gap DownShould You Sell? - MarketBeat

Oct 21, 2024
pulisher
Oct 19, 2024

Jones Trading Initiates Coverage of Rapport Therapeutics (RAPP) with Buy Recommendation - MSN

Oct 19, 2024
pulisher
Oct 18, 2024

Rapport Therapeutics (NASDAQ:RAPP) Trading Down 2.7%Time to Sell? - MarketBeat

Oct 18, 2024
pulisher
Oct 18, 2024

This Rapport Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - MSN

Oct 18, 2024
pulisher
Oct 17, 2024

When (RAPP) Moves Investors should Listen - Stock Traders Daily

Oct 17, 2024
pulisher
Oct 16, 2024

Rapport Therapeutics (NASDAQ:RAPP) Sets New 1-Year HighTime to Buy? - MarketBeat

Oct 16, 2024
pulisher
Oct 16, 2024

Millennium Management LLC Makes New $2.72 Million Investment in Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat

Oct 16, 2024
pulisher
Oct 15, 2024

Rapport Therapeutics (NASDAQ:RAPP) Short Interest Up 32.4% in September - MarketBeat

Oct 15, 2024
pulisher
Oct 14, 2024

Rapport Therapeutics (NASDAQ:RAPP) Stock Price Up 5.3%What's Next? - MarketBeat

Oct 14, 2024
pulisher
Oct 11, 2024

75,516 Shares in Rapport Therapeutics (NASDAQ:RAPP) Purchased by The Manufacturers Life Insurance Company - MarketBeat

Oct 11, 2024
pulisher
Oct 10, 2024

Two more Mass. biotechs raise $330M in IPOs, to debut on Nasdaq - The Business Journals

Oct 10, 2024
pulisher
Oct 06, 2024

(RAPP) On The My Stocks Page - Stock Traders Daily

Oct 06, 2024
pulisher
Oct 04, 2024

Rapport Therapeutics (NASDAQ:RAPP) Trading Up 7%Should You Buy? - MarketBeat

Oct 04, 2024
pulisher
Oct 02, 2024

Rapport Therapeutics (NASDAQ:RAPP) Shares Down 4.1% - MarketBeat

Oct 02, 2024
pulisher
Oct 01, 2024

Logos Global Management LP Makes New Investment in Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat

Oct 01, 2024
pulisher
Sep 30, 2024

Perceptive Advisors LLC Acquires New Position in Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat

Sep 30, 2024
pulisher
Sep 28, 2024

Rapport Therapeutics (NASDAQ:RAPP) Trading 6.2% Higher - MarketBeat

Sep 28, 2024
pulisher
Sep 25, 2024

(RAPP) Technical Data - Stock Traders Daily

Sep 25, 2024
pulisher
Sep 24, 2024

ARCH Venture Management LLC Makes New $86.73 Million Investment in Rapport Therapeutics (NASDAQ:RAPP) - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

ARCH Venture Management LLC Invests $86.73 Million in Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat

Sep 24, 2024
pulisher
Sep 24, 2024

GC Therapeutics Raises $65M Series A - citybiz

Sep 24, 2024
pulisher
Sep 23, 2024

Biogen, Alnylam-partnered Camp4 Therapeutics unveils IPO plans - The Business Journals

Sep 23, 2024
pulisher
Sep 23, 2024

Rapport Therapeutics Inc. (RAPP) rating initates by TD Cowen - Knox Daily

Sep 23, 2024
pulisher
Sep 23, 2024

GC Therapeutics Raises $65M in Series A Funding - FinSMEs

Sep 23, 2024
pulisher
Sep 19, 2024

Rapport Therapeutics (NASDAQ:RAPP) Shares Down 2.4% - MarketBeat

Sep 19, 2024
pulisher
Sep 19, 2024

Rapport Therapeutics (NASDAQ:RAPP) Stock Price Up 4.7% - Defense World

Sep 19, 2024
pulisher
Sep 18, 2024

Reckitt shares up on report of potential homecare asset sale By Investing.com - Investing.com South Africa

Sep 18, 2024
pulisher
Sep 18, 2024

Rhythm Pharmaceuticals initiated with a Buy at H.C. Wainwright - TipRanks

Sep 18, 2024
pulisher
Sep 18, 2024

Quest Partners LLC Sells 5,882 Shares of iRobot Co. (NASDAQ:IRBT) - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

Sofinnova Investments Inc. Invests $45.39 Million in Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat

Sep 18, 2024
pulisher
Sep 18, 2024

Rapport Therapeutics (NASDAQ:RAPP) Trading 4.7% Higher - MarketBeat

Sep 18, 2024
pulisher
Sep 17, 2024

RNAZ’s Financial Health: Exploring TransCode Therapeutics Inc’s Debt-to-Equity Ratio of 1.79 - The InvestChronicle

Sep 17, 2024
pulisher
Sep 17, 2024

Trimble and Platform Science pushed hard to get deal done before Vegas meeting - Yahoo Finance

Sep 17, 2024
pulisher
Sep 16, 2024

Johnson & Johnson Invests $58.11 Million in Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat

Sep 16, 2024
pulisher
Sep 16, 2024

Rapport Therapeutics (NASDAQ:RAPP) Shares Gap Up to $19.00 - MarketBeat

Sep 16, 2024
pulisher
Sep 15, 2024

(RAPP) Trading Advice - Stock Traders Daily

Sep 15, 2024
pulisher
Sep 13, 2024

TD Asset Management Inc Takes Position in Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat

Sep 13, 2024
pulisher
Sep 13, 2024

TD Asset Management Inc Invests $2.36 Million in Rapport Therapeutics (NASDAQ:RAPP) - Defense World

Sep 13, 2024
pulisher
Sep 13, 2024

Shares of two Mass. biotech IPOs rise on first day of trading - The Business Journals

Sep 13, 2024
pulisher
Sep 11, 2024

Rapport Therapeutics (NASDAQ:RAPP) Stock Price Down 5.5% - MarketBeat

Sep 11, 2024
pulisher
Sep 11, 2024

The Potential Rise in the Price of Rapport Therapeutics Inc. (RAPP) following insiders activity - Knox Daily

Sep 11, 2024
pulisher
Sep 10, 2024

IPO class of 2024 shows value recovery despite mixed stock performance - BioWorld Online

Sep 10, 2024
pulisher
Sep 06, 2024

Rapport Therapeutics (NASDAQ:RAPP) Shares Gap Up to $21.20 - MarketBeat

Sep 06, 2024
pulisher
Sep 05, 2024

Rapport Therapeutics to Present at Upcoming Epilepsy Medical Conferences - GlobeNewswire

Sep 05, 2024

Finanzdaten der Rapport Therapeutics Inc-Aktie (RAPP)

Es liegen keine Finanzdaten für Rapport Therapeutics Inc (RAPP) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Rapport Therapeutics Inc-Aktie (RAPP) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
HEALY JAMES
Director
Jun 10 '24
Buy
17.00
558,824
9,500,008
1,863,327
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):